Stocks to Watch: Bancroft Uranium Inc (OTC BB: BCFT), Celsius Holdings, Inc. (OTC BB:CSUH) , IceWEB, Inc. (OTCBB: IWEB), Seattle Genetics Inc. (Nasdaq: SGEN), eFoodSafety.com (OTC BB:EFSF)
Featured Stock: Bancroft Uranium Inc
(OTC BB: BCFT)
Current Price (0.81)
http://www.smallcapstockanalyst.com/
Bancroft Announces Further Drilling Results at Monmouth Uranium Project
Scottsdale AZ, June 4, 2008 ---- Bancroft Uranium Inc. (OTCBB: BCFT) (“Bancroft” or the “Company”) is pleased to announce further drilling results from the Spring 2008 surface drill program conducted at the Monmouth Uranium Project, near Bancroft Ontario. The Company today is releasing assay results from drill holes 08-16 through 08-28 as outlined below.
The 2008 Exploration Phase 1 drill program commenced on February 25th and was designed to focus on areas in and around the historical drill results from the 1969 program bringing it into modern N.I. Policy 43-101 compliance, a recognized world mining standard. The drilling is also designed to extend the known strike length of the skarn which hosts the uranium mineralization with the aim of expanding the current estimated 1,800,000 lbs U3O8 potential at Monmouth.
This second series of drilling assays and intervals are from holes drilled over an additional 200 feet of strike length exposure of the host rock skarn (altered limestone) as follow up to results released on May 29th from the initial 300 feet. In total, the combined results cover drilling conducted over 500 feet of strike on the deposit. The historical drilling in 1969 covered a zone approximately 1,500 feet in length.
Assays of 0.747lb/51.4’ and 1.134lb/23.9’ in holes 08-24 and 08-25 represent the best results from this series of holes. Significant results are as follows. Assays are noted as lb representing lbs/ton U3O8 over feet:
08-16 - 0.309 lb/ 29.6’ from 49.6 to 79.2 feet,
08-17- 0.337lb/10.9’ from 35.2 to 46.1 feet and 0.469lb/2.4’ from 92.1 to 94.5 feet
08-18- 0.316lb/5.2’ from 15.1 to 20.3 feet; 0.125lb/4.6’ from 37.1 to 41.7 feet and 0.467lb/8.0’ from 55.0 to 63.0 feet
08-19- 0.397lb/49.2’ from 5.2 to 54.4 feet including 0.365lb/9.0’ from 5.2 to 14.2 feet and 0.646lb/10.4’ from 18.9 to 29.3 feet and 0.565lb/14.5’ from 34.0 to 48.5 feet. Also 0.595lb/17.3’ from 71.0 to 88.3 feet
08-22 - 0.717lb/18.5’ from 73.0 to 91.5 feet
08-23 - 0.401lb/9.8’ from 39.4 to 49.2 feet; 0.374lb/7.7’ from 55.4 to 63.1 feet; 0.794lb/33.3’ from 81.6 to 114.9 feet and 0.486lb/3.9’ from 125.7 to 129.6 feet
08-24 - 0.495lb/19.8’ from 56.0 to 75.8 feet and 0.747lb/51.4’ from 104.9 to 156.3 feet
08-25 - 1.134lb/23.9’ from 103.7 to 127.6 feet
08-25A - 0.420lb/55.1’ from 69.0 to 124.1 feet including 0.363lb/26.7’ from 73.9 to 100.6 feet and 0.656lb/19.2’ from 104.9 to 124.1 feet
08-26 - 0.389lb/31.9’ from 46.8 to 78.7 feet; 0.526lb/5.0’ from 119.0 to 124.0 feet and 0.507lb/17.1’ from 143.4 to 160.5 feet and 0.369lb/21.1’ from 188.7 to 209.8 feet
08-26A - 0.633lb/36.7’ from 135.9 to 172.6 feet including 0.788lb/18.1’ from 135.9 to 154.0 feet and 0.683lb/13.0’ from 159.6 to 172.6 feet.
08-27 - 5.377lb/2.1’ from 38.2 to 40.3 feet and 0.611lb/10.2’ from 66.2 to 76.4 feet
08-28 - 0.643lb/5.1’ from 52.5 to 57.6 feet; 0.352lb/14.2’ from 124.0 to 138.2 feet including 0.304lb/5.0’ from 124.0 to 129.0 feet and 0.521lb/6.5’ from131.7 to 138.2 feet; 0.525lb/26.3’ from 168.0 to 194.3 feet including 1.618lb/3.3’ from 172.8 to 176.1 feet and 0.578lb/13.7’ from 180.6 to 194.3 feet.
To date, Company engineers have verified the location, thickness and flat lying geometry of the uranium bearing skarn system intersected in the historical drilling. U3O8 assays have been returned from both uraninite bearing bright orange-colored calcite alteration in the skarn and from several pegmatite bodies in and adjacent to the skarn package. Initial assay results from the skarn rocks appear to validate the historical data. The geological modeling of the deposit is now coming into focus with the alteration zone rock package dipping at a fairly consistent 25-30 degrees, amenable to a potential open pit scenario.
All of Bancroft Uranium’s exploration programs are designed and supervised by Qualified Persons (“QP”) under the N.I. Policy 43-101, who ensure that programs are carried out using current industry “Best Practices”. The spring 2008 drilling program was supervised by Murray McGill P.Geo (QP). The NQ size core was logged by Mr. McGill and split on-site. Half core samples were analyzed using standard Delayed Neutron Counting (DNC) methods by Activation Laboratories in Ancaster, Ontario. Activation Laboratories employs rigorous in-house QA/QC procedures in the DNC process.
Bancroft will release a third series of drill results shortly.
For inquiries from the public and media concerning the Monmouth Uranium Project please contact Greenspirit Strategies at 1-877-54 GREEN or 1-877-544-7336. For shareholder and investor information please contact investor relations at 1-866-860-2995
ABOUT BANCROFT URANIUM INC. (OTCBB: BCFT)
Bancroft Uranium Inc. is an exploration Company which intends to develop Uranium assets in North America. Bancroft’s initial asset, the Monmouth Uranium Project is envisioned to have the potential of a low cost, open pit uranium producer located close to infrastructure and end product buyers.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements", as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of our exploration program at our uranium properties and any anticipated future production. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with mineral exploration and development stage exploration companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-KSB for the most recent fiscal year, our quarterly reports on Form 10-QSB and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
Bancroft Uranium Inc.
- - - - - - - - - - - - - - - - - -
P. L. Hammond, C.A.
President and Chief Executive Officer
To find out more about Bancroft Uranium Inc. (OTCBB: BCFT), visit our website at http://www.bancrofturanium.com/.
Public and Media Information: 1-877-544-7336
Shareholder and Investor Information: 1-866-860-2995
Source: Bancroft Uranium Inc.
For an in-depth analyst report, please visit : http://www.smallcapstockanalyst.com/
Celsius Holdings, Inc.
(OTC BB:CSUH)
Current Price (0.08)
www.SmallCapStockAnalyst.com
DELRAY BEACH, FL----Jun 5, 2008 -- Celsius Holdings, Inc. (OTC BB:CSUH.OB - News) announced today their distribution partnership with Refreshment Services, Inc. ("RSI"). Celsius®, the original, great tasting calorie burner, a healthier choice that has been clinically tested and shown to burn calories by raising metabolism for over a 3 hour period, now has distribution in additional portions of Illinois, Iowa, Indiana, and Missouri. Celsius Holdings, Inc. (OTC BB:CSUH.OB - News) manufactures Celsius through its wholly owned operating subsidiary, Celsius, Inc. Celsius, Inc. is quickly gaining attention in the emerging $36 billion functional food and beverage industry, as the creator of the negative calorie beverage category and as a pioneer and leader in developing healthier beverage choices. Celsius, Inc. is building unique distribution strategies to gain broad penetration in all channels serving its consumer targets in all geographies. The continued mission of Celsius, Inc. is to create healthy refreshment through science and innovation and growth through passion and integrity. For more information about Celsius and Celsius, Inc., please visit http://www.celsius.com. For investor information, please visit http://www.redchip.com/.
IceWEB, Inc.
(OTCBB: IWEB)
Current Price (0.39)
www.SmallCapStockAnalyst.com
HERNDON, Va.--June 5--IceWEB, Inc. (OTCBB:IWEB) www.IceWEB.com announced today that the Company has signed a formal Teaming Agreement with Premier Technical Services Corporation (Premier), a Virginia-based IT and engineering firm, naming IceWEB as a subcontractor on the team for development and implementation of a LEED-certified green data center in Page County, Virginia. The new state-of-the-art, energy efficient, large-scale data center is a part of a planned $16.5 million data center and office complex in development by Premier, who will also serve as prime contractor on the project. Headquartered just outside of Washington, D.C., IceWEB is a leading source for branded On Demand products and services and proprietary enterprise data storage solutions, as well as best-of-class products, services and solutions offered in partnership with a wide range of global technology leaders. Its customer base includes U.S. government agencies, enterprise companies, small to medium sized businesses (SMB) and tech-savvy consumers.
Seattle Genetics Inc.
(Nasdaq: SGEN)
Current Price (9.02)
www.SmallCapStockAnalyst.com
SEATTLE--June 5--Seattle Genetics, Inc. (Nasdaq:SGEN - News) today announced final data from the phase I clinical trial of SGN-40 in patients with relapsed or refractory non-Hodgkin lymphoma. SGN-40 is a humanized monoclonal antibody being developed under a worldwide collaboration agreement with Genentech, Inc. Multiple objective responses were achieved and SGN-40 was generally well tolerated with no maximum tolerated dose identified. The data were reported during an oral presentation at the International Conference on Malignant Lymphoma (ICML) being held in Lugano, Switzerland. Seattle Genetics is a clinical stage biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease. The company has a worldwide collaboration with Genentech to develop and commercialize SGN-40. Seattle Genetics also has two other product candidates in ongoing clinical trials: SGN-33 and SGN-35. In addition, the company has developed proprietary antibody-drug conjugate (ADC) technology comprised of highly potent synthetic drugs and stable linkers for attaching the drugs to monoclonal antibodies. Seattle Genetics has collaborations for its ADC technology with a number of leading biotechnology and pharmaceutical companies, including Genentech, Bayer, CuraGen, Progenics and MedImmune, as well as an ADC co-development agreement with Agensys.
eFoodSafety.com
(OTC BB:EFSF)
Current Price (0.15)
www.SmallCapStockAnalyst.com
SCOTTSDALE, Ariz.--June 5--eFoodSafety.com, Inc. (OTCBB: EFSF, www.efoodsafety.com), a researcher, developer, and marketer of whole food and nutraceutical products, provides an update on OraPhyte™, its product being tested by major universities for efficacy in controlling nematodes, widespread agricultural parasites. eFoodSafety.com, Inc., through its subsidiaries, offers technologies that enhance food and health conditions. It develops various products, including anthrax sporicidal, a germicidal cleaner, a wound care antiseptic, an herbicide, and an insect repellent. The company also distributes various products to physicians who then prescribe the products for their patients. It primarily distributes Talsyn-CI/bid scar cream that facilitates and improves the appearance, redness, and strength of scars; Cinnergen, a non prescription liquid whole food nutritional supplement that promotes glucose metabolism; and Trimmendous, a weight loss formula focusing on the body's 24-hour metabolic processes. eFoodSafety.com markets its products in the United States and internationally through various nonexclusive distribution agreements, as well as trade shows, and industry-related events and seminars. The company was incorporated in 1998 and is based in Scottsdale, Arizona.
Smallcapstockanalyst.com is owned and operated by Iron Consulting LLC
Verify all claims and do your own due diligence. Iron Consulting profiles are not a solicitation or recommendation to buy, sell or hold securities. Iron Consulting is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Iron Consulting is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), Smallcapstockanalyst.com is owned and operated by Iron Consulting. Iron Consulting www.ironconsultinginc.com has receive fifty thousand dollars from Equity Alliance Intl. for one months of internet marketing services, from Equity Alliance Int. LLC www.equityallianceir.com for its marketing and consulting services. Neither Iron Consulting nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Iron Consulting receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Iron Consulting statements and opinions and such statements and opinions cannot be considered independent. Iron Consulting and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements ar e made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Iron Consulting services are often paid for using free-trading shares. Iron Consulting may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.
